Malaria vaccine: the latest breakthrough is far from a cure
The IndependentSign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. “A vaccine that is highly efficacious – 90 per cent or so – that’s not in view at this point” Mary Hamel, coordinator, WHO With children in some regions getting multiple episodes of malaria in a year, even a partially effective vaccine could have a big impact, Mary Hamel, coordinator of the program for WHO, said in an interview. open image in gallery GlaxoSmithKline and its partners are ready to deploy a vaccine for malaria “A vaccine that is highly efficacious – 90 per cent or so – that’s not in view at this point,” she says. It will be a pathfinder.” The effort underscores the challenge of developing products for poorer countries that carry costs extending well beyond clinical trials and approvals, says Ashley Birkett, director of Path’s Malaria Vaccine Initiative. “This is the first malaria vaccine,” she says, “not the last”.